Celldex (CLDX) – Analyst Comments
-
TD Cowen Starts Celldex Therapeutics (CLDX) at Outperform; 'barzolvolimab has blockbuster potential'
-
Celldex Therapeutics (CLDX) PT Raised to $80 at H.C. Wainwright
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CLDX Stock Lookup